Skip to main content


Weitere Artikel dieser Ausgabe durch Wischen aufrufen

07.11.2018 | original article | Ausgabe 7-8/2019 Open Access

Wiener Medizinische Wochenschrift 7-8/2019

Lip creams with propolis special extract GH 2002 0.5% versus aciclovir 5.0% for herpes labialis (vesicular stage)

Randomized, controlled double-blind study

Wiener Medizinische Wochenschrift > Ausgabe 7-8/2019
Jagienka Jautová, Hana Zelenková, Katarína Drotarová, Alena Nejdková, Božena Grünwaldová, Marie Hladiková


A lip cream with special propolis extract GH 2002 at a concentration of 0.5% (199 patients) was tested against aciclovir 5% (198 patients) in the treatment of episodes of herpes labialis under double-blind conditions. Upon inclusion, all patients were in the vesicular phase. Application was five times daily of approximately 0.2 g of cream to the entire upper and lower lip. The primary parameter was the difference in time between groups to complete encrustation or epithelization of the lesions. Secondary endpoints were the course of typical herpes symptoms (pain, burning and itching, tension and swelling), the global assessment of efficacy and the safety of application. The predefined clinical situation was reached after a (median) 3 days with propolis and 4 days with aciclovir (p < 0.0001). Significant differences in favor of propolis were also found for all secondary parameters. No allergic reactions, local irritations or other adverse events occurred.

Unsere Produktempfehlungen

Abo für kostenpflichtige Inhalte

Über diesen Artikel

Weitere Artikel der Ausgabe 7-8/2019

Wiener Medizinische Wochenschrift 7-8/2019 Zur Ausgabe